Argus analyst David Toung downgraded Catalent to Sell from Buy in light of the pending merger between Catalent and Novo Holdings. The firm will be dropping coverage of Catalent and will remove the stock from its universe of coverage in the next 30 days, the analyst noted.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CTLT: